New portable blood testing device could allow patient health to be monitored at home through an app

King's College London spinout Algocyte has developed a portable, UKCA-marked blood testing device that uses sensors and AI algorithms to analyze finger-prick blood samples at home and transmit results via an app. Intended for patients needing frequent monitoring, such as those receiving chemotherapy or clozapine, the system tracks health indicators over time and has the potential to alleviate clinical testing burdens on health systems like the NHS.

Summary written by AI Business Lens with an AI model from the article at medicalxpress.com. It is not the article, and the publisher has not reviewed it. For publishers.

Read the original at medicalxpress.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, class prep, and an exercise. All built from the full article. Three are free with an account. Stories stay on the brief for 14 days; after that this page keeps the link to the original.

More in Biomedical Engineering

• How Roche drives AI outcomes in a changing worldCIO.com · September 16, 2026
• From 7,000 drugs to one active against resistant strains: AI advances pneumonia drug repurposingMedical Xpress · September 16, 2026
• AI Isn’t a Therapist, but Many Teens Are Treating It Like OneMedCity News · September 16, 2026
• Study finds AI scribes save doctors' time and may ease administrative burdenMedical Xpress · September 16, 2026
• Augmented eye clinic shows why AI-native systems work where standalone algorithms don'tMedical Xpress · September 16, 2026